To reauthorize the Kay Hagan Tick Act, and for other purposes.
This bill continues federal funding through 2030 for programs that track, prevent, and respond to illnesses spread by ticks, mosquitoes, and fleas, such as Lyme disease and West Nile virus. It provides grants to state, local, and tribal health departments to help them monitor bug populations and control disease outbreaks. The bill also supports regional research centers to improve testing, prevention, and public health training.
What this bill touches.
Who it helps · who it burdens.
Who it helps
- Regional centers of excellence in vector-borne diseasesReceives expanded statutory objectives to increase capacity to identify, report, prevent, and respond to vector-borne diseases (Sec. 1(a)(2)), and benefits from extended authorization of appropriations through FY 2030 (Sec. 1(a)(3)).
- State and local health departmentsReceives continued eligibility for federal assistance and grants to address vector-borne diseases through extended funding authorizations through FY 2030 (Sec. 1(b)).
Who opposes it
- Tick-Borne Disease Working GroupLoses its designated statutory role as a required entity consulted in the development and updating of the national vector-borne disease strategy (Sec. 1(a)(1)).
The provisions, in plain language.
Modifies the process for developing and updating the national vector-borne disease strategy by allowing consultation with relevant experts and individuals rather than a specific tick-borne disease working group.
Expands the objectives for regional centers of excellence to include building capacity to identify, report, prevent, and respond to vector-borne diseases.
Extends the authorization of appropriations for the national vector-borne disease strategy and regional centers of excellence through fiscal year 2030.
Extends the authorization of appropriations for federal assistance and grants to help health departments address vector-borne diseases through fiscal year 2030.